Bionano Genomics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BNGO and other ETFs, options, and stocks.About BNGO
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics.
CEORobert Erik Holmlin
CEORobert Erik Holmlin
Employees100
Employees100
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2003
Founded2003
Employees100
Employees100
BNGO Key Statistics
Market cap15.90M
Market cap15.90M
Price-Earnings ratio-0.04
Price-Earnings ratio-0.04
Dividend yield—
Dividend yield—
Average volume294.01K
Average volume294.01K
High today$1.66
High today$1.66
Low today$1.52
Low today$1.52
Open price$1.61
Open price$1.61
Volume278.69K
Volume278.69K
52 Week high$22.80
52 Week high$22.80
52 Week low$1.50
52 Week low$1.50
Stock Snapshot
The current Bionano Genomics(BNGO) stock price is $1.60, with a market capitalization of 15.9M. The stock trades at a price-to-earnings (P/E) ratio of -0.04.
During the trading session on 2025-11-08, Bionano Genomics(BNGO) shares reached a daily high of $1.66 and a low of $1.52. At a current price of $1.60, the stock is +5.3% higher than the low and still -3.6% under the high.
Trading activity shows a volume of 278.69K, compared to an average daily volume of 294.01K.
The stock's 52-week range extends from a low of $1.50 to a high of $22.80.
The stock's 52-week range extends from a low of $1.50 to a high of $22.80.
People also own
Based on the portfolios of people who own BNGO. This list is generated using Robinhood data, and it’s not a recommendation.